AI-Powered News Analysis•Compare coverage across the political spectrum
GoodPointsNews
Admin
Back to Dashboard
Hims & Hers offers GLP-1 weight-loss drugs, men's health treatments in Australia - Reuters

Hims & Hers offers GLP-1 weight-loss drugs, men's health treatments in Australia - Reuters

Hims & Hers offers GLP-1 weight-loss drugs, men's health treatments in Australia Reuters

August 31, 2026 at 07:10 PM Original source
1 agencies covered this story

Coverage by Political Leaning

See how different sides of the spectrum reported this story

Left
0 articles
No coverage
Lean Left
0 articles
No coverage
Center
1 articles
Lean Right
0 articles
No coverage
Right
0 articles
No coverage

Key People

No people linked to this story

Locations

Australia

Tags

australia glp-1 hims and hers men's health weight loss

All Coverage

Hims & Hers offers GLP-1 weight-loss drugs, men's health treatments in Australia - Reuters
Reutersvia rss

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxNZ0pNenQtRDFUckp6SldZT0U1OEJlMGdlM0RwTjZWODZLQW01WnJoaWNFNzM1dllKN1hGRG1DbldtOU9fRy1MeVRqTXd3X1VIWTRSSUF4azNlSDhldlZXYnNCa0tBNm91eUJkdk1kMW1VUWZ6RV9sMzhQSkU0RU10QVk1N0ZPYktUVEIwTEhSMFJDdS1aRHVXcmp4ZjFSZFRmbXlfQndnYk9vSmRwUUo3YTdDdlEtQk8zYk4wTzFacnZJWXBJUHB4SHFibzJyaGZpd01FMkY2QzNYeTV0ZHc?oc=5" target="_blank">Hims & Hers offers GLP-1 weight-loss drugs, men's health treatments in Australia</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

100%

Similar Stories

Related coverage based on topic and tags

Novo Nordisk to license experimental GLP-1 pill from China's Hengrui - Reuters

Novo Nordisk to license experimental GLP-1 pill from China's Hengrui Reuters

September 29, 2026 at 04:47 AM

Lilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com

Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com

September 29, 2026 at 10:15 PM

Experimental Lilly combination drug tops Zepbound in weight-loss trial - Reuters

Experimental Lilly combination drug tops Zepbound in weight-loss trial Reuters

September 30, 2026 at 05:34 PM

Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com

Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com

September 30, 2026 at 10:30 PM

Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study - Reuters

Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study Reuters

September 30, 2026 at 09:57 AM

Amazon, GoodRx target US prescription subscribers as health insurance coverage slips - reuters.com

Amazon, GoodRx target US prescription subscribers as health insurance coverage slips reuters.com

September 29, 2026 at 10:54 AM